1243 results
Publication
Monthly communication regarding buyback programs - September 2022
As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication
2022 HALF YEAR RESULTS Additional information on the Group’s strategy
Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.
Publication
2022 half-year results
This document has been prepared by Vetoquinol for the sole purpose of presenting the half-year results for the fiscal year 2022, on September 15, 2022.
Publication
2022 HALF YEAR RESULTS
Sales: €271m (up 6.0% as reported) Essentials sales: €154m (up 9.8% as reported) EBIT before depreciation of acquired assets: €52m (19.0% of sales) Net income - Group share: €21m (7.9% of sales) EBITDA: €62m (22.9% of sales)
Basic page
Key share information
Date of stock market introduction: 16 /11/2006 Trading market: Euronext Paris Compartiment B LEI: 969500YPOAETQIK48R39 Eligible PEA-PME Share type: Ordinary share Nominal value: €2.5 Date of end of financial year: 31 December Company who manages liquidity contract: ODDO BHF Corporate Broking
Publication
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2022
As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »